STOCK TITAN

Standex Intl Financials

SXI
FY2026 annual
Revenue $891.6M +12.8% YoY
Net Income $104.6M +87.6% YoY
EPS (Diluted) $8.67 +86.9% YoY
Free Cash Flow $64.4M +56.0% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE June

Standex Intl (SXI) reported $891.6M in revenue for fiscal year 2026, up 12.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SXI FY2026

Debt-funded expansion enlarged Standex’s asset base, while renewed scale helped restore operating leverage and profitability.

In FY2025, total assets jumped to $1.57B while debt-to-equity reached 0.8x, indicating that the expansion was financed materially with borrowing rather than accumulated operating resources. By FY2026, the operating margin recovered to 21.7%, but free-cash-flow margin was only 7.2%, showing that improved earnings still translated into cash less fully after reinvestment and financing demands.

Gross margin reached 41.7% in FY2026, up from 39.9% in FY2025, so the recovery included better underlying product economics rather than relying solely on expense reduction. The sharper operating-margin rebound suggests fixed operating costs were absorbed more efficiently as sales expanded.

Operating cash flow rose to $89.6M in FY2026, while free cash flow was $64.4M after $25.2M of capital expenditures; reinvestment therefore consumed a meaningful portion of internally generated cash. Cash of $178.7M and a 2.4x current ratio still provide short-term coverage, although liquidity is tighter than in FY2024.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 64 / 100
Financial Health Score 64/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Standex Intl's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
82

Standex Intl has an operating margin of 21.7%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 82/100, reflecting efficient cost management and pricing power. This is up from 11.8% the prior year.

Growth
68

Standex Intl's revenue grew 12.8% year-over-year to $891.6M, a solid pace of expansion. This earns a growth score of 68/100.

Leverage
37

Standex Intl has a moderate D/E ratio of 0.69. This balance of debt and equity financing earns a leverage score of 37/100.

Liquidity
67

With a current ratio of 2.40, Standex Intl holds $2.40 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 67/100.

Cash Flow
57

Standex Intl has a free cash flow margin of 7.2%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
71

Standex Intl earns a strong 13.9% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 71/100. This is up from 7.8% the prior year.

Altman Z-Score Safe
5.00

Standex Intl scores 5.00, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.8B) relative to total liabilities ($830.5M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Standex Intl passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
0.86x

For every $1 of reported earnings, Standex Intl generates $0.86 in operating cash flow ($89.6M OCF vs $104.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe
6.30x

Standex Intl earns $6.30 in operating income for every $1 of interest expense ($193.6M vs $30.7M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$891.6M
YoY+12.8%
5Y CAGR+6.3%
10Y CAGR+1.7%

Standex Intl generated $891.6M in revenue in fiscal year 2026. This represents an increase of 12.8% from the prior year.

EBITDA
$232.2M
YoY+80.0%
5Y CAGR+20.2%
10Y CAGR+10.2%

Standex Intl's EBITDA was $232.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 80.0% from the prior year.

Net Income
$104.6M
YoY+87.6%
5Y CAGR+23.5%
10Y CAGR+7.2%

Standex Intl reported $104.6M in net income in fiscal year 2026. This represents an increase of 87.6% from the prior year.

EPS (Diluted)
$8.67
YoY+86.9%
5Y CAGR+23.9%
10Y CAGR+7.8%

Standex Intl earned $8.67 per diluted share (EPS) in fiscal year 2026. This represents an increase of 86.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$64.4M
YoY+56.0%
5Y CAGR+0.8%

Standex Intl generated $64.4M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 56.0% from the prior year.

Cash & Debt
$178.7M
YoY+71.0%
5Y CAGR+5.6%
10Y CAGR+3.9%

Standex Intl held $178.7M in cash against $518.0M in long-term debt as of fiscal year 2026.

Dividends Per Share
$1.34
YoY+42.6%
5Y CAGR+7.3%

Standex Intl paid $1.34 per share in dividends in fiscal year 2026. This represents an increase of 42.6% from the prior year.

Shares Outstanding
12M
YoY+0.4%
5Y CAGR-0.2%
10Y CAGR-0.4%

Standex Intl had 12M shares outstanding in fiscal year 2026. This represents an increase of 0.4% from the prior year.

Margins & Returns

Gross Margin
41.7%
YoY+1.8pp
5Y CAGR+5.0pp
10Y CAGR+8.2pp

Standex Intl's gross margin was 41.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 1.8 percentage points from the prior year.

Operating Margin
21.7%
YoY+9.9pp
5Y CAGR+12.7pp
10Y CAGR+12.3pp

Standex Intl's operating margin was 21.7% in fiscal year 2026, reflecting core business profitability. This is up 9.9 percentage points from the prior year.

Net Margin
11.7%
YoY+4.7pp
5Y CAGR+6.2pp
10Y CAGR+4.8pp

Standex Intl's net profit margin was 11.7% in fiscal year 2026, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.

Return on Equity
13.9%
YoY+6.0pp
5Y CAGR+6.7pp
10Y CAGR-0.2pp

Standex Intl's ROE was 13.9% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 6.0 percentage points from the prior year.

Capital Allocation

R&D Spending
$24.2M
YoY+14.2%

Standex Intl invested $24.2M in research and development in fiscal year 2026. This represents an increase of 14.2% from the prior year.

Share Buybacks
$4.4M
YoY-55.6%
5Y CAGR-27.0%
10Y CAGR-2.4%

Standex Intl spent $4.4M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 55.6% from the prior year.

Capital Expenditures
$25.2M
YoY-11.1%
5Y CAGR+3.0%

Standex Intl invested $25.2M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 11.1% from the prior year.

SXI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SXI annual income statement
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Revenue$891.6M+12.8%$790.1M+9.6%$720.6M-2.8%$741.0M+0.8%$735.3M+12.1%$656.2M+8.6%$604.5M-5.5%$639.9M+7.5%$595.5M-8.1%$647.9M-13.8%$751.6M-2.7%$772.1M+7.8%$716.2M+6.4%$673.4M+10.3%$610.6M
Cost of Revenue$519.6M+9.4%$474.9M+8.3%$438.6M-3.8%$456.0M-2.0%$465.4M+12.2%$415.0M+6.7%$389.1M-4.0%$405.3M+9.7%$369.5M-14.5%$432.3M-13.4%$499.3M-4.8%$524.7M+9.8%$477.9M+5.0%$455.2M+11.3%$408.9M
Gross Profit$372.0M+18.0%$315.2M+11.8%$282.0M-1.1%$285.1M+5.6%$269.9M+11.9%$241.3M+12.0%$215.5M-8.2%$234.7M+3.8%$226.0M+4.8%$215.6M-14.5%$252.3M+1.9%$247.5M+3.9%$238.3M+9.2%$218.2M+8.2%$201.7M
R&D Expenses$24.2M+14.2%$21.2M+3.4%$20.5MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$4.4M0.0%$4.4M
SG&A Expenses$219.3M+13.4%$193.4M+14.0%$169.6M-1.6%$172.3M+1.4%$169.9M+4.2%$163.1M+9.8%$148.5M-1.2%$150.3M+6.9%$140.7M-3.0%$145.0M-14.8%$170.2M+2.6%$165.8M0.0%$165.8M+7.9%$153.6M+8.6%$141.5M
Operating Income$193.6M+106.9%$93.5M-8.0%$101.7M-40.5%$171.1M+93.8%$88.3M+49.2%$59.2M-2.3%$60.5M-23.8%$79.5M+1.7%$78.1M+37.3%$56.9M-19.1%$70.3M-10.6%$78.6M+19.4%$65.9M+6.4%$61.9M-2.3%$63.4M
Interest Expense$30.7M+28.3%$23.9M+426.7%$4.5M-15.9%$5.4M-8.0%$5.9M-2.0%$6.0M-19.8%$7.5M-30.5%$10.8M+34.0%$8.0M+98.6%$4.0M+40.8%$2.9M-9.2%$3.2M+40.6%$2.2M-8.9%$2.5M+8.3%$2.3M
Income Tax$34.3M+209.0%$11.1M-48.5%$21.5M-13.2%$24.8M+25.2%$19.8M+39.9%$14.2M+8.4%$13.1M-30.1%$18.7M-50.9%$38.0M+221.7%$11.8M-27.5%$16.3M-21.9%$20.9M+15.6%$18.1M+18.4%$15.2M-2.9%$15.7M
Net Income$104.6M+87.6%$55.8M-23.7%$73.1M-47.4%$139.0M+126.4%$61.4M+68.3%$36.5M+80.7%$20.2M-70.3%$67.9M+85.5%$36.6M-21.4%$46.5M-10.6%$52.1M-4.9%$54.7M+27.7%$42.9M-4.4%$44.8M+45.1%$30.9M
EPS (Diluted)$8.67+86.9%$4.64-24.4%$6.14-47.0%$11.58+128.9%$5.06+70.4%$2.97+82.2%$1.63-69.7%$5.38+88.1%$2.86-21.6%$3.65-10.5%$4.08-4.4%$4.27+27.5%$3.35-4.6%$3.51+45.0%$2.42

SXI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SXI annual balance sheet
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Total Assets$1.6B+1.2%$1.6B+55.9%$1.0B-1.9%$1.0B+9.7%$934.4M-2.9%$962.2M+3.4%$930.9M+1.0%$921.9M+0.5%$916.9M+5.7%$867.7M+25.7%$690.5M+4.8%$659.1M+14.0%$578.2M+13.2%$510.6M+6.4%$479.8M
Current Assets$551.8M+14.7%$480.9M+11.8%$430.1M-11.0%$483.3M+27.5%$379.0M+1.2%$374.4M+12.8%$332.0M-0.6%$333.9M-13.0%$384.0M+6.4%$360.9M+1.4%$355.8M+6.1%$335.4M+11.8%$299.9M+16.1%$258.3M+3.6%$249.3M
Cash & Equivalents$178.7M+71.0%$104.5M-32.2%$154.2M-21.2%$195.7M+86.7%$104.8M-23.1%$136.4M+14.8%$118.8M+27.6%$93.1M-15.0%$109.6M+23.8%$88.6M-27.4%$122.0M+26.9%$96.1M+29.4%$74.3M+45.4%$51.1M-6.7%$54.7M
Inventory$129.0M-0.8%$130.0M+49.2%$87.1M-11.6%$98.5M-6.5%$105.3M+14.7%$91.9M+8.0%$85.0M+11.4%$76.3M-26.8%$104.3M-12.6%$119.4M+13.3%$105.4M-2.7%$108.3M+11.6%$97.1M+18.6%$81.8M+12.0%$73.1M
Accounts Receivable$172.9M+0.1%$172.7M+42.3%$121.4M-1.7%$123.4M+5.4%$117.1M+6.5%$109.9M+11.9%$98.2M-5.0%$103.4M-13.7%$119.8M-5.7%$127.1M+22.2%$104.0M-5.9%$110.5M+2.6%$107.7M+9.9%$98.0M-1.4%$99.4M
Goodwill$581.6M-4.7%$610.3M+117.0%$281.3M+6.2%$264.8M-1.2%$267.9M-3.6%$278.1M+2.5%$271.2M-1.0%$273.8M+34.2%$204.1M-15.9%$242.7M+54.2%$157.4M+1.7%$154.7M+22.8%$126.0M+12.6%$111.9M+11.2%$100.6M
Total Liabilities$830.5M-2.9%$855.2M+123.0%$383.6M-8.1%$417.5M-4.0%$435.1M-4.5%$455.8M-2.9%$469.2M+2.6%$457.6M-1.8%$466.1M+1.6%$459.0M+43.2%$320.5M+3.2%$310.5M+30.8%$237.4M+8.1%$219.6M-7.3%$236.9M
Current Liabilities$229.5M+37.5%$167.0M+30.9%$127.6M-9.5%$141.0M-6.5%$150.8M+4.9%$143.7M+17.0%$122.9M-13.2%$141.6M-12.2%$161.3M+0.9%$160.0M+19.3%$134.1M-3.4%$138.8M-1.7%$141.2M+19.2%$118.5M+1.4%$116.8M
Long-Term Debt$518.0M-6.3%$552.5M+271.1%$148.9M-14.2%$173.4M-0.8%$174.8M-12.4%$199.5M+0.2%$199.2M+0.8%$197.6M+2.0%$193.8M+0.9%$192.0M+108.4%$92.1M-9.5%$101.8M+125.8%$45.1M-10.0%$50.1M+0.1%$50.0M
Total Equity$755.2M+6.1%$711.7M+14.5%$621.5M+2.3%$607.4M+21.6%$499.3M-1.4%$506.4M+9.7%$461.6M-0.6%$464.3M+3.0%$450.8M+10.3%$408.7M+10.5%$370.0M+6.1%$348.6M+2.3%$340.7M+17.1%$291.0M+19.8%$242.9M
Retained Earnings$1.2B+7.9%$1.1B+3.7%$1.1B+5.7%$1.0B+14.0%$901.4M+5.7%$852.5M+3.0%$827.7M+1.1%$818.3M+7.5%$761.4M+6.3%$716.6M+5.7%$678.0M+7.1%$632.9M+8.4%$584.0M+7.0%$546.0M+8.1%$505.2M

SXI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SXI annual cash flow statement
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Operating Cash Flow$89.6M+28.7%$69.6M-24.9%$92.7M+2.0%$90.8M+16.8%$77.7M-7.0%$83.6M+76.9%$47.2M-35.6%$73.3M+13.0%$64.9M+2.3%$63.4M-21.0%$80.3M+25.4%$64.0M-8.9%$70.3M+16.8%$60.2M+37.8%$43.7M
Capital Expenditures$25.2M-11.1%$28.3M+39.6%$20.3M-16.4%$24.3M+1.6%$23.9M+9.8%$21.8M+1.1%$21.5M-33.8%$32.5M+37.9%$23.6MN/AN/AN/AN/AN/A$9.9M
Free Cash Flow$64.4M+56.0%$41.3M-43.0%$72.4M+8.8%$66.5M+23.6%$53.8M-12.9%$61.8M+140.4%$25.7M-37.0%$40.8M-1.3%$41.4MN/AN/AN/AN/AN/A$33.7M
Investing Cash Flow$43.1M+108.6%-$503.4M-716.9%-$61.6M-248.3%$41.6M+233.9%-$31.0M+20.6%-$39.1M-6235.7%-$617K+98.8%-$49.7M-53.9%-$32.3M+82.0%-$179.1M-522.1%-$28.8M+63.3%-$78.5M-136.8%-$33.2M+37.1%-$52.7M-713.8%$8.6M
Financing Cash Flow-$56.6M-114.9%$380.5M+649.8%-$69.2M-72.8%-$40.0M+42.3%-$69.4M-118.8%-$31.7M-67.2%-$19.0M+50.3%-$38.2M-220.7%-$11.9M-114.1%$84.7M+508.2%-$20.7M-146.5%$44.6M+400.7%-$14.8M-35.9%-$10.9M-14.4%-$9.5M
Dividends Paid$16.2M+7.7%$15.0M+8.1%$13.9M+7.1%$13.0M+6.0%$12.2M+7.0%$11.4M+7.9%$10.6M+7.9%$9.8M+10.6%$8.9M+13.2%$7.9M+14.7%$6.8M+216.2%-$5.9M-20.7%-$4.9M-22.7%-$4.0M-14.8%-$3.5M
Share Buybacks$4.4M-55.6%$9.9M-68.9%$31.8M+24.7%$25.5M-18.8%$31.4M+48.2%$21.2M+103.1%$10.4M-68.7%$33.4M+1159.2%$2.7M-66.0%$7.8M+38.5%$5.6M-45.6%$10.4M+32.9%$7.8M-8.4%$8.5M+54.1%$5.5M

SXI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SXI annual financial ratios
MetricFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12
Gross Margin41.7%+1.8pp39.9%+0.8pp39.1%+0.7pp38.5%+1.8pp36.7%-0.1pp36.8%+1.1pp35.6%-1.0pp36.7%-1.3pp38.0%+4.7pp33.3%-0.3pp33.6%+1.5pp32.0%-1.2pp33.3%+0.9pp32.4%-0.6pp33.0%
Operating Margin21.7%+9.9pp11.8%-2.3pp14.1%-9.0pp23.1%+11.1pp12.0%+3.0pp9.0%-1.0pp10.0%-2.4pp12.4%-0.7pp13.1%+4.3pp8.8%-0.6pp9.4%-0.8pp10.2%+1.0pp9.2%0.0pp9.2%-1.2pp10.4%
Net Margin11.7%+4.7pp7.1%-3.1pp10.1%-8.6pp18.8%+10.4pp8.3%+2.8pp5.6%+2.2pp3.3%-7.3pp10.6%+4.5pp6.2%-1.0pp7.2%+0.3pp6.9%-0.2pp7.1%+1.1pp6.0%-0.7pp6.7%+1.6pp5.1%
Return on Equity13.9%+6.0pp7.8%-3.9pp11.8%-11.1pp22.9%+10.6pp12.3%+5.1pp7.2%+2.8pp4.4%-10.3pp14.6%+6.5pp8.1%-3.3pp11.4%-2.7pp14.1%-1.6pp15.7%+3.1pp12.6%-2.8pp15.4%+2.7pp12.7%
Return on Assets6.6%+3.0pp3.6%-3.7pp7.3%-6.3pp13.6%+7.0pp6.6%+2.8pp3.8%+1.6pp2.2%-5.2pp7.4%+3.4pp4.0%-1.4pp5.4%-2.2pp7.5%-0.8pp8.3%+0.9pp7.4%-1.4pp8.8%+2.3pp6.4%
Current Ratio2.40-0.5x2.88-0.5x3.37-0.1x3.43+0.9x2.51-0.1x2.60-0.1x2.70+0.3x2.360.0x2.38+0.1x2.26-0.4x2.65+0.2x2.42+0.3x2.12-0.1x2.180.0x2.13
Debt-to-Equity0.69-0.1x0.78+0.5x0.240.0x0.29-0.1x0.350.0x0.390.0x0.430.0x0.430.0x0.430.0x0.47+0.2x0.250.0x0.29+0.2x0.130.0x0.170.0x0.21
FCF Margin7.2%+2.0pp5.2%-4.8pp10.0%+1.1pp9.0%+1.7pp7.3%-2.1pp9.4%+5.2pp4.3%-2.1pp6.4%-0.6pp6.9%N/AN/AN/AN/AN/A5.5%

Similar Companies

Frequently Asked Questions

What is Standex Intl's annual revenue?

Standex Intl (SXI) reported $891.6M in total revenue for fiscal year 2026. This represents a 12.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Standex Intl's revenue growing?

Standex Intl (SXI) revenue grew by 12.8% year-over-year, from $790.1M to $891.6M in fiscal year 2026.

Is Standex Intl profitable?

Yes, Standex Intl (SXI) reported a net income of $104.6M in fiscal year 2026, with a net profit margin of 11.7%.

Standex Intl (SXI) reported diluted earnings per share of $8.67 for fiscal year 2026. This represents a 86.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Standex Intl (SXI) had EBITDA of $232.2M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Standex Intl (SXI) had $178.7M in cash and equivalents against $518.0M in long-term debt.

Standex Intl (SXI) had a gross margin of 41.7% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Standex Intl (SXI) had an operating margin of 21.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Standex Intl (SXI) had a net profit margin of 11.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Yes, Standex Intl (SXI) paid $1.34 per share in dividends during fiscal year 2026.

Standex Intl (SXI) has a return on equity of 13.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Standex Intl (SXI) generated $64.4M in free cash flow during fiscal year 2026. This represents a 56.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Standex Intl (SXI) generated $89.6M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Standex Intl (SXI) had $1.6B in total assets as of fiscal year 2026, including both current and long-term assets.

Standex Intl (SXI) invested $25.2M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Standex Intl (SXI) invested $24.2M in research and development during fiscal year 2026.

Yes, Standex Intl (SXI) spent $4.4M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Standex Intl (SXI) had 12M shares outstanding as of fiscal year 2026.

Standex Intl (SXI) had a current ratio of 2.40 as of fiscal year 2026, which is generally considered healthy.

Standex Intl (SXI) had a debt-to-equity ratio of 0.69 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Standex Intl (SXI) had a return on assets of 6.6% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Standex Intl (SXI) has an Altman Z-Score of 5.00, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Standex Intl (SXI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Standex Intl (SXI) has an earnings quality ratio of 0.86x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Standex Intl (SXI) has an interest coverage ratio of 6.30x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Standex Intl (SXI) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top